INSULET CORP (PODD)

US45784P1012 - Common Stock

260.12  -1.04 (-0.4%)

After market: 260.12 0 (0%)

Fundamental Rating

7

Taking everything into account, PODD scores 7 out of 10 in our fundamental rating. PODD was compared to 188 industry peers in the Health Care Equipment & Supplies industry. While PODD belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. PODD is growing strongly while it is still valued neutral. This is a good combination! These ratings could make PODD a good candidate for growth investing.



8

1. Profitability

1.1 Basic Checks

In the past year PODD was profitable.
In the past year PODD had a positive cash flow from operations.
PODD had positive earnings in each of the past 5 years.
Of the past 5 years PODD 4 years had a positive operating cash flow.

1.2 Ratios

PODD's Return On Assets of 13.91% is amongst the best of the industry. PODD outperforms 95.72% of its industry peers.
PODD has a better Return On Equity (37.65%) than 98.93% of its industry peers.
The Return On Invested Capital of PODD (8.69%) is better than 88.24% of its industry peers.
PODD had an Average Return On Invested Capital over the past 3 years of 4.58%. This is below the industry average of 8.23%.
The last Return On Invested Capital (8.69%) for PODD is above the 3 year average (4.58%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 13.91%
ROE 37.65%
ROIC 8.69%
ROA(3y)3%
ROA(5y)2.07%
ROE(3y)10.71%
ROE(5y)9.71%
ROIC(3y)4.58%
ROIC(5y)3.92%

1.3 Margins

PODD's Profit Margin of 21.22% is amongst the best of the industry. PODD outperforms 94.65% of its industry peers.
In the last couple of years the Profit Margin of PODD has grown nicely.
Looking at the Operating Margin, with a value of 15.42%, PODD belongs to the top of the industry, outperforming 86.10% of the companies in the same industry.
In the last couple of years the Operating Margin of PODD has grown nicely.
The Gross Margin of PODD (69.36%) is better than 80.75% of its industry peers.
PODD's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 15.42%
PM (TTM) 21.22%
GM 69.36%
OM growth 3Y31.55%
OM growth 5Y12.81%
PM growth 3Y152.86%
PM growth 5Y83.43%
GM growth 3Y2.01%
GM growth 5Y0.8%

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), PODD is creating some value.
Compared to 1 year ago, PODD has more shares outstanding
The number of shares outstanding for PODD has been increased compared to 5 years ago.
Compared to 1 year ago, PODD has an improved debt to assets ratio.

2.2 Solvency

PODD has an Altman-Z score of 7.24. This indicates that PODD is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 7.24, PODD belongs to the top of the industry, outperforming 85.03% of the companies in the same industry.
PODD has a debt to FCF ratio of 6.41. This is a slightly negative value and a sign of low solvency as PODD would need 6.41 years to pay back of all of its debts.
The Debt to FCF ratio of PODD (6.41) is better than 75.40% of its industry peers.
A Debt/Equity ratio of 1.21 is on the high side and indicates that PODD has dependencies on debt financing.
PODD has a Debt to Equity ratio of 1.21. This is amonst the worse of the industry: PODD underperforms 80.21% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.21
Debt/FCF 6.41
Altman-Z 7.24
ROIC/WACC1
WACC8.68%

2.3 Liquidity

PODD has a Current Ratio of 3.68. This indicates that PODD is financially healthy and has no problem in meeting its short term obligations.
PODD has a better Current ratio (3.68) than 62.03% of its industry peers.
PODD has a Quick Ratio of 2.80. This indicates that PODD is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 2.80, PODD is in the better half of the industry, outperforming 60.96% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.68
Quick Ratio 2.8

9

3. Growth

3.1 Past

PODD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 129.49%, which is quite impressive.
Measured over the past years, PODD shows a very strong growth in Earnings Per Share. The EPS has been growing by 122.39% on average per year.
Looking at the last year, PODD shows a very strong growth in Revenue. The Revenue has grown by 27.42%.
PODD shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 24.66% yearly.
EPS 1Y (TTM)129.49%
EPS 3Y104.08%
EPS 5Y122.39%
EPS Q2Q%26.76%
Revenue 1Y (TTM)27.42%
Revenue growth 3Y23.34%
Revenue growth 5Y24.66%
Sales Q2Q%25.7%

3.2 Future

The Earnings Per Share is expected to grow by 20.32% on average over the next years. This is a very strong growth
Based on estimates for the next years, PODD will show a quite strong growth in Revenue. The Revenue will grow by 15.95% on average per year.
EPS Next Y15.6%
EPS Next 2Y20.03%
EPS Next 3Y21.66%
EPS Next 5Y20.32%
Revenue Next Year23.5%
Revenue Next 2Y20.97%
Revenue Next 3Y19.77%
Revenue Next 5Y15.95%

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 72.66, PODD can be considered very expensive at the moment.
PODD's Price/Earnings ratio is a bit cheaper when compared to the industry. PODD is cheaper than 66.31% of the companies in the same industry.
When comparing the Price/Earnings ratio of PODD to the average of the S&P500 Index (28.53), we can say PODD is valued expensively.
Based on the Price/Forward Earnings ratio of 66.38, the valuation of PODD can be described as expensive.
Based on the Price/Forward Earnings ratio, PODD is valued a bit cheaper than 67.38% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of PODD to the average of the S&P500 Index (23.40), we can say PODD is valued expensively.
Industry RankSector Rank
PE 72.66
Fwd PE 66.38

4.2 Price Multiples

PODD's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. PODD is cheaper than 67.38% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, PODD is valued a bit cheaper than 71.66% of the companies in the same industry.
Industry RankSector Rank
P/FCF 83.59
EV/EBITDA 49.06

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates PODD does not grow enough to justify the current Price/Earnings ratio.
PODD has an outstanding profitability rating, which may justify a higher PE ratio.
PODD's earnings are expected to grow with 21.66% in the coming years. This may justify a more expensive valuation.
PEG (NY)4.66
PEG (5Y)0.59
EPS Next 2Y20.03%
EPS Next 3Y21.66%

0

5. Dividend

5.1 Amount

No dividends for PODD!.
Industry RankSector Rank
Dividend Yield N/A

INSULET CORP

NASDAQ:PODD (11/15/2024, 8:00:00 PM)

After market: 260.12 0 (0%)

260.12

-1.04 (-0.4%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap18.24B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 72.66
Fwd PE 66.38
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)4.66
PEG (5Y)0.59
Profitability
Industry RankSector Rank
ROA 13.91%
ROE 37.65%
ROCE
ROIC
ROICexc
ROICexgc
OM 15.42%
PM (TTM) 21.22%
GM 69.36%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.66
Health
Industry RankSector Rank
Debt/Equity 1.21
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 3.68
Quick Ratio 2.8
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)129.49%
EPS 3Y104.08%
EPS 5Y
EPS Q2Q%
EPS Next Y15.6%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)27.42%
Revenue growth 3Y23.34%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y